First-line Replacement Maintenance of Envafolimab in Advanced NSCLC

NCT05465733 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Non-Small-Cell Lung

Interventions

DRUG: Envafolimab;Pemetrexed

Sponsor

First Affiliated Hospital Xi'an Jiaotong University